Abstract:Macrophage mitochondrial dysfunction is associated with immunosuppression and poor prognosis of septic patients. Mitochondrial fragmentation drives mitochondrial dysfunction. Our previous study has found that S1PR2 regulates macrophage phagocytosis during sepsis, while the role of S1PR2 in immunosuppression and the mechanisms remain further studied. This study aimed to unveil the relationship between macrophage mitochondrial fragmentation and sepsis-induced immunosuppression, as well as the S1PR2-related mechanisms thereof. Peripheral blood monocytes were collected from healthy controls (n = 12), nonseptic critical controls (n = 13) and septic patients (n = 19). Peritoneal macrophages were harvested from wildtype and S1pr2-/- mice (MMRRC strain iD, 12830) after cecal ligation and puncture (CLP). Mitochondrial ultrastructure was evaluated using transmission electron microscopy. The impact of mitochondrial ultrastructure alteration on immunosuppression of monocytes-macrophages was evaluated. Compared with nonseptic and healthy controls, peripheral blood monocytes from septic patients exhibited increased S1PR2 expression, mitochondrial fragmentation, and mitochondrial dysfunction. Mitochondrial fragmentation was negatively associated with HLA-DR expression. S1PR2 expression was positively correlated with mitochondrial fragmentation and negatively correlated with HLA-DR expression. In mice subjected to CLP, S1PR2 depletion ameliorated macrophage mitochondrial fragmentation and dysfunction, boosted immunity, and improved survival. Mechanistically, in response to sepsis, S1PR2 activates ROCK I to induce Drp1 phosphorylation, resulting in Drp1-dependent mitochondrial fragmentation of macrophages. Drp1 inhibition by Mdivi-1 mitigated S1PR2-induced macrophage immunosuppression and improved the prognosis of mice following CLP. In conclusion, S1PR2-induced mitochondrial fragmentation is a crucial factor mediating septic immunosuppression, highlighting its potential as a promising therapeutic target in sepsis.

Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives

Endothelial Cell Dysfunction and Targeted Therapeutic Drugs in Sepsis

Potential Therapy Strategy: Targeting Mitochondrial Dysfunction in Sepsis

Mechanism of Mitophagy and Its Role in Sepsis Induced Organ Dysfunction: A Review

Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy

The emerging role of mtDNA release in sepsis: Current evidence and potential therapeutic targets

Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure

Mitochondria-Derived Damage-Associated Molecular Patterns In Sepsis: From Bench To Bedside

Macrophage S1PR2 Drives Sepsis-induced Immunosuppression by Exacerbating Mitochondrial Fragmentation

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

Progress in the Mechanism of Mitochondrial Dysfunction in Septic Cardiomyopathy

Mitochondrial dysfunction and acute renal injury in sepsis

An Overview on Mitochondrial-Based Therapies in Sepsis-Related Myocardial Dysfunction: Mitochondrial Transplantation as a Promising Approach

Sepsis-Induced Myocardial Dysfunction (SIMD): the Pathophysiological Mechanisms and Therapeutic Strategies Targeting Mitochondria

Mitochondrial dysfunction and resuscitation in sepsis

Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy

Molecular Pathways in Sepsis Pathogenesis: Recent Advances and Therapeutic Avenues

Mitochondrial Damage in Sepsis

[Research of Progress of Mitochondria in the Pathogenesis of Sepsis].

The pathogenesis and potential therapeutic targets in sepsis

Identification of biomarkers and pathways of mitochondria in sepsis patients